Abstract
Summary
The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.
LPI (LP Information)' newest research report, the “DPT Vaccination Industry Forecast” looks at past sales and reviews total world DPT Vaccination sales in 2022, providing a comprehensive analysis by region and market sector of projected DPT Vaccination sales for 2023 through 2029. With DPT Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DPT Vaccination industry.
This Insight Report provides a comprehensive analysis of the global DPT Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DPT Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global DPT Vaccination market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DPT Vaccination and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DPT Vaccination.
The global DPT Vaccination market size is projected to grow from US$ 5075.1 million in 2022 to US$ 6514.2 million in 2029; it is expected to grow at a CAGR of 6514.2 from 2023 to 2029.
Global key DPT vaccines manufacturers include Sanofi Pasteur, GSK etc.The top 2 companies hold a share over 90%.Europe is the largest market, with a share about 34%, followed by North America and Asia-Pacific with the share about 27% and 25%.
This report presents a comprehensive overview, market shares, and growth opportunities of DPT Vaccination market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
DTaP
Tdap
DTwP
Segmentation by application
12 Months Below
12 Months Above
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Key Questions Addressed in this Report
What is the 10-year outlook for the global DPT Vaccination market?
What factors are driving DPT Vaccination market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do DPT Vaccination market opportunities vary by end market size?
How does DPT Vaccination break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “DPT Vaccination Industry Forecast” looks at past sales and reviews total world DPT Vaccination sales in 2022, providing a comprehensive analysis by region and market sector of projected DPT Vaccination sales for 2023 through 2029. With DPT Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DPT Vaccination industry.
This Insight Report provides a comprehensive analysis of the global DPT Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DPT Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global DPT Vaccination market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DPT Vaccination and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DPT Vaccination.
The global DPT Vaccination market size is projected to grow from US$ 5075.1 million in 2022 to US$ 6514.2 million in 2029; it is expected to grow at a CAGR of 6514.2 from 2023 to 2029.
Global key DPT vaccines manufacturers include Sanofi Pasteur, GSK etc.The top 2 companies hold a share over 90%.Europe is the largest market, with a share about 34%, followed by North America and Asia-Pacific with the share about 27% and 25%.
This report presents a comprehensive overview, market shares, and growth opportunities of DPT Vaccination market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
DTaP
Tdap
DTwP
Segmentation by application
12 Months Below
12 Months Above
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Key Questions Addressed in this Report
What is the 10-year outlook for the global DPT Vaccination market?
What factors are driving DPT Vaccination market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do DPT Vaccination market opportunities vary by end market size?
How does DPT Vaccination break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global DPT Vaccination Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for DPT Vaccination by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for DPT Vaccination by Country/Region, 2018, 2022 & 2029
2.2 DPT Vaccination Segment by Type
2.2.1 DTaP
2.2.2 Tdap
2.2.3 DTwP
2.3 DPT Vaccination Sales by Type
2.3.1 Global DPT Vaccination Sales Market Share by Type (2018-2023)
2.3.2 Global DPT Vaccination Revenue and Market Share by Type (2018-2023)
2.3.3 Global DPT Vaccination Sale Price by Type (2018-2023)
2.4 DPT Vaccination Segment by Application
2.4.1 12 Months Below
2.4.2 12 Months Above
2.5 DPT Vaccination Sales by Application
2.5.1 Global DPT Vaccination Sale Market Share by Application (2018-2023)
2.5.2 Global DPT Vaccination Revenue and Market Share by Application (2018-2023)
2.5.3 Global DPT Vaccination Sale Price by Application (2018-2023)
3 Global DPT Vaccination by Company
3.1 Global DPT Vaccination Breakdown Data by Company
3.1.1 Global DPT Vaccination Annual Sales by Company (2018-2023)
3.1.2 Global DPT Vaccination Sales Market Share by Company (2018-2023)
3.2 Global DPT Vaccination Annual Revenue by Company (2018-2023)
3.2.1 Global DPT Vaccination Revenue by Company (2018-2023)
3.2.2 Global DPT Vaccination Revenue Market Share by Company (2018-2023)
3.3 Global DPT Vaccination Sale Price by Company
3.4 Key Manufacturers DPT Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers DPT Vaccination Product Location Distribution
3.4.2 Players DPT Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for DPT Vaccination by Geographic Region
4.1 World Historic DPT Vaccination Market Size by Geographic Region (2018-2023)
4.1.1 Global DPT Vaccination Annual Sales by Geographic Region (2018-2023)
4.1.2 Global DPT Vaccination Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic DPT Vaccination Market Size by Country/Region (2018-2023)
4.2.1 Global DPT Vaccination Annual Sales by Country/Region (2018-2023)
4.2.2 Global DPT Vaccination Annual Revenue by Country/Region (2018-2023)
4.3 Americas DPT Vaccination Sales Growth
4.4 APAC DPT Vaccination Sales Growth
4.5 Europe DPT Vaccination Sales Growth
4.6 Middle East & Africa DPT Vaccination Sales Growth
5 Americas
5.1 Americas DPT Vaccination Sales by Country
5.1.1 Americas DPT Vaccination Sales by Country (2018-2023)
5.1.2 Americas DPT Vaccination Revenue by Country (2018-2023)
5.2 Americas DPT Vaccination Sales by Type
5.3 Americas DPT Vaccination Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC DPT Vaccination Sales by Region
6.1.1 APAC DPT Vaccination Sales by Region (2018-2023)
6.1.2 APAC DPT Vaccination Revenue by Region (2018-2023)
6.2 APAC DPT Vaccination Sales by Type
6.3 APAC DPT Vaccination Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe DPT Vaccination by Country
7.1.1 Europe DPT Vaccination Sales by Country (2018-2023)
7.1.2 Europe DPT Vaccination Revenue by Country (2018-2023)
7.2 Europe DPT Vaccination Sales by Type
7.3 Europe DPT Vaccination Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa DPT Vaccination by Country
8.1.1 Middle East & Africa DPT Vaccination Sales by Country (2018-2023)
8.1.2 Middle East & Africa DPT Vaccination Revenue by Country (2018-2023)
8.2 Middle East & Africa DPT Vaccination Sales by Type
8.3 Middle East & Africa DPT Vaccination Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of DPT Vaccination
10.3 Manufacturing Process Analysis of DPT Vaccination
10.4 Industry Chain Structure of DPT Vaccination
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 DPT Vaccination Distributors
11.3 DPT Vaccination Customer
12 World Forecast Review for DPT Vaccination by Geographic Region
12.1 Global DPT Vaccination Market Size Forecast by Region
12.1.1 Global DPT Vaccination Forecast by Region (2024-2029)
12.1.2 Global DPT Vaccination Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global DPT Vaccination Forecast by Type
12.7 Global DPT Vaccination Forecast by Application
13 Key Players Analysis
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur DPT Vaccination Product Portfolios and Specifications
13.1.3 Sanofi Pasteur DPT Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK DPT Vaccination Product Portfolios and Specifications
13.2.3 GSK DPT Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Mitsubishi Tanabe Pharma
13.3.1 Mitsubishi Tanabe Pharma Company Information
13.3.2 Mitsubishi Tanabe Pharma DPT Vaccination Product Portfolios and Specifications
13.3.3 Mitsubishi Tanabe Pharma DPT Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mitsubishi Tanabe Pharma Main Business Overview
13.3.5 Mitsubishi Tanabe Pharma Latest Developments
13.4 KM Biologics
13.4.1 KM Biologics Company Information
13.4.2 KM Biologics DPT Vaccination Product Portfolios and Specifications
13.4.3 KM Biologics DPT Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 KM Biologics Main Business Overview
13.4.5 KM Biologics Latest Developments
13.5 Wuhan Institute of Biological Products
13.5.1 Wuhan Institute of Biological Products Company Information
13.5.2 Wuhan Institute of Biological Products DPT Vaccination Product Portfolios and Specifications
13.5.3 Wuhan Institute of Biological Products DPT Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Wuhan Institute of Biological Products Main Business Overview
13.5.5 Wuhan Institute of Biological Products Latest Developments
13.6 Walvax Biotechnology
13.6.1 Walvax Biotechnology Company Information
13.6.2 Walvax Biotechnology DPT Vaccination Product Portfolios and Specifications
13.6.3 Walvax Biotechnology DPT Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Walvax Biotechnology Main Business Overview
13.6.5 Walvax Biotechnology Latest Developments
13.7 Chengdu Institute of Biological Products
13.7.1 Chengdu Institute of Biological Products Company Information
13.7.2 Chengdu Institute of Biological Products DPT Vaccination Product Portfolios and Specifications
13.7.3 Chengdu Institute of Biological Products DPT Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Chengdu Institute of Biological Products Main Business Overview
13.7.5 Chengdu Institute of Biological Products Latest Developments
13.8 Minhai Biotechnology
13.8.1 Minhai Biotechnology Company Information
13.8.2 Minhai Biotechnology DPT Vaccination Product Portfolios and Specifications
13.8.3 Minhai Biotechnology DPT Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Minhai Biotechnology Main Business Overview
13.8.5 Minhai Biotechnology Latest Developments
14 Research Findings and Conclusion